Johannesburg. Thursday, 27 February 2020. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed:
VESTING IN SHARE APPRECIATION RIGHTS AND SALE OF ORDINARY SHARES BY A PRESCRIBED OFFICER
| Name of prescribed officer: | J van Heerden |
| Nature of transaction: | The off-market issuance of shares to settle SARS |
| Date of vesting of SARS issued in 2014: | 17 November 2019 |
| Date on which SARS issued in 2014 will lapse: | 17 November 2020 |
| Number of 2014 SARS vested to date: | 15 305 |
| 2014 SARS issue value per share: | R18.41 |
| 1-day Volume Weighted Average price of shares | R68.1417 |
| Nature of transaction: | On market sale of shares |
| Date of sale: | 25 February 2020 |
| Number of ordinary shares issued to settle 2014 SARS: | 11 170 |
| Selling price per share: | R65.5172 |
| Day’s highest sale price: | R67.56 |
| Day’s lowest sale price: | R61.72 |
| Proceeds for total on market sale: | R731 827.12 |
| Class of securities: | Ordinary shares |
| Nature and extent of prescribed officer’s interest: | Direct beneficial |
Prior clearance was obtained in respect of the above dealings by the directors.
For more details contact:
Marian van der Walt
Executive: Investor Relations
+27(0)82 888 1242 (mobile)
Johannesburg, South Africa
27 February 2020
Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited